Business Description
Kadimastem Ltd
ISIN : IL0011284614
Compare
Compare
Traded in other countries / regions
KDST.IsraelKMSTF.USA IPO Date
2015-01-07Description
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.66 | |||||
| Equity-to-Asset | -0.52 | |||||
| Debt-to-Equity | -1.45 | |||||
| Debt-to-EBITDA | -0.66 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 44.3 | |||||
| 3-Year EPS without NRI Growth Rate | 42 | |||||
| 3-Year FCF Growth Rate | 43.5 | |||||
| 3-Year Book Growth Rate | 36.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.05 | |||||
| 9-Day RSI | 40.77 | |||||
| 14-Day RSI | 39.78 | |||||
| 6-1 Month Momentum % | -11.71 | |||||
| 12-1 Month Momentum % | -36.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | |||||
| Quick Ratio | 0.7 | |||||
| Cash Ratio | 0.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.2 | |||||
| Shareholder Yield % | -22.53 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -118.44 | |||||
| ROIC % | -114.9 | |||||
| ROC (Joel Greenblatt) % | -362.52 | |||||
| ROCE % | -1212 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.85 | |||||
| EV-to-EBITDA | -2.3 | |||||
| EV-to-FCF | -1.97 | |||||
| Earnings Yield (Greenblatt) % | -54.05 | |||||
| FCF Yield % | -56.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kadimastem Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | |||
| EPS (TTM) (₪) | -2.8 | ||
| Beta | 0 | ||
| Volatility % | 21.75 | ||
| 14-Day RSI | 39.78 | ||
| 14-Day ATR (₪) | 0.301539 | ||
| 20-Day SMA (₪) | 4.9099 | ||
| 12-1 Month Momentum % | -36.2 | ||
| 52-Week Range (₪) | 4.351 - 10.4 | ||
| Shares Outstanding (Mil) | 4.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kadimastem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kadimastem Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kadimastem Ltd Frequently Asked Questions
What is Kadimastem Ltd(XTAE:KDST)'s stock price today?
The current price of XTAE:KDST is ₪4.70. The 52 week high of XTAE:KDST is ₪10.40 and 52 week low is ₪4.35.
When is next earnings date of Kadimastem Ltd(XTAE:KDST)?
The next earnings date of Kadimastem Ltd(XTAE:KDST) is .
Does Kadimastem Ltd(XTAE:KDST) pay dividends? If so, how much?
Kadimastem Ltd(XTAE:KDST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers